Advertisement
Advertisement

UNCY

UNCY logo

Unicycive Therapeutics, Inc. Common Stock

6.70
USD
Sponsored
+0.51
+8.21%
Feb 06, 16:00 UTC -5
Closed
exchange

After-Market

6.68

-0.01
-0.21%

UNCY Earnings Reports

Positive Surprise Ratio

UNCY beat 7 of 18 last estimates.

39%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Unicycive Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 12, 2025, UNCY reported earnings of -0.33 USD per share (EPS) for Q3 25, beating the estimate of -0.56 USD, resulting in a 41.88% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.31% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, Unicycive Therapeutics, Inc. Common Stock reported EPS of -$0.33, beating estimates by 41.88%, and revenue of $0.00, 0% as expectations.
The stock price moved up 7.31%, changed from $4.79 before the earnings release to $5.14 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Unicycive Therapeutics, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement